by Amy Berger | Sep 23, 2022 | News, Publications and Press
IITRI is happy to share the good news from our collaboration with the National Cancer Institute (NCI) on their program focusing on an inhaled drug against SARS-CoV-2. Our team here at IITRI was contracted to perform toxicology studies for their drug...
by Amy Berger | Apr 19, 2022 | News, Publications and Press
IITRI is happy to share the promising news of one of our Sponsors, Ascletis Pharma, Inc. Our team here at IITRI was contracted to perform in vitro testing of their drug candidates for antiviral effects against multiple strains of SARS-CoV-2 as well as cytotoxicity....
by Amy Berger | Feb 15, 2022 | Events, News
We’re excited to be attending the 61st Annual Meeting and ToxExpo (March 27-31, 2022) in sunny San Diego after two years of delayed and virtual meetings. You can find us at the Expo at Booth #2307 from March 28-30 in the Exhibit Hall (ground level) from 9am-...
by Amy Berger | Aug 24, 2021 | Blog, News
August is National Immunization Awareness Month (NIAM) which serves as reminder of the importance of vaccination for people of all ages. We’re proud to play a role in the development and testing of vaccines here at IITRI. IITRI has decades of experience...
by Amy Berger | Jul 26, 2021 | Blog, News
STARTING OFF ON THE RIGHT FOOT Our inhalation services include preliminary method development activities as the necessary first step for inhalation toxicology studies. The selection and characterization of the test atmosphere to be realistic and extensively measured...
by Amy Berger | Jul 7, 2021 | News, Publications and Press
IITRI is proud to share the promising news from multiple sponsors of COVID-19 in vitro and in vivo studies. Links below to press releases and recent publications. Congrats all! New IITRI Co-Author Publication: Scalable live-attenuated SARS-CoV-2 vaccine...
Recent Comments